251 related articles for article (PubMed ID: 35670620)
1. Clinical Evaluation of a Line-Probe Assay for Tuberculosis Detection and Drug-Resistance Prediction in Namibia.
Günther G; Saathoff E; Rachow A; Ekandjo H; Diergaardt A; Marais N; Lange C; Nepolo E
Microbiol Spectr; 2022 Jun; 10(3):e0025922. PubMed ID: 35670620
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.
Rufai SB; Kumar P; Singh A; Prajapati S; Balooni V; Singh S
J Clin Microbiol; 2014 Jun; 52(6):1846-52. PubMed ID: 24648554
[TBL] [Abstract][Full Text] [Related]
3. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
[TBL] [Abstract][Full Text] [Related]
4. Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF.
Soedarsono S; Mertaniasih NM; Hasan H; Kusmiati T; Permatasari A; Kusumaningrum D; Wijaksono W
Int J Mycobacteriol; 2022; 11(4):429-434. PubMed ID: 36510930
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of the Xpert
Maya T; Wilfred A; Lubinza C; Mfaume S; Mafie M; Mtunga D; Kingalu A; Mgina N; Petrucka P; Doulla BE; Ngadaya E; Mfinanga SG; Mnyambwa NP
BMC Infect Dis; 2024 Jul; 24(1):672. PubMed ID: 38965482
[TBL] [Abstract][Full Text] [Related]
6. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Penn-Nicholson A; Georghiou SB; Ciobanu N; Kazi M; Bhalla M; David A; Conradie F; Ruhwald M; Crudu V; Rodrigues C; Myneedu VP; Scott L; Denkinger CM; Schumacher SG;
Lancet Infect Dis; 2022 Feb; 22(2):242-249. PubMed ID: 34627496
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Diagnostic Accuracy Study of Abbott RealTi
Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
[TBL] [Abstract][Full Text] [Related]
8. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
10. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
11. Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.
Cao Y; Parmar H; Gaur RL; Lieu D; Raghunath S; Via N; Battaglia S; Cirillo DM; Denkinger C; Georghiou S; Kwiatkowski R; Persing D; Alland D; Chakravorty S
J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298611
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
13. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
[TBL] [Abstract][Full Text] [Related]
14. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
Rice JP; Seifert M; Moser KS; Rodwell TC
PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
[TBL] [Abstract][Full Text] [Related]
15. Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
Chen X; Li R; Ge S; Li Y; Cai C; Weng T; Zhang Y; Jiang J; Feng Z; Chen Y; Zhang Y; Ma J; Persing DH; Chen J; Tang YW; Sun F; Zhang W
J Clin Microbiol; 2023 Jun; 61(6):e0183222. PubMed ID: 37249422
[TBL] [Abstract][Full Text] [Related]
16. To Test or Not? Xpert MTB/RIF as an Alternative to Smear Microscopy to Guide Line Probe Assay Testing for Drug-Resistant Tuberculosis.
Pillay S; de Vos M; Sohn H; Ghebrekristos Y; Dolby T; Warren RM; Theron G
J Clin Microbiol; 2023 Jul; 61(7):e0001723. PubMed ID: 37367228
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis value with Xpert Mtb/RIF assay for cervical tuberculous lymphadenitis].
Yang CQ; Liu XY; Du RH; Cao TZ; Dai XY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(17):1338-1340. PubMed ID: 29798226
[No Abstract] [Full Text] [Related]
18. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
19. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
[TBL] [Abstract][Full Text] [Related]
20. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
